Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
about
PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerancePathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusThe double edged sword of the immune response: mutational analysis of a murine anti-pneumococcal, anti-DNA antibodyCD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.Establishment of monoclonal anti-retroviral gp70 autoantibodies from MRL/lpr lupus mice and induction of glomerular gp70 deposition and pathology by transfer into non-autoimmune mice.Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice.Deficiency of the type I interferon receptor protects mice from experimental lupus.Immune enhancement by novel vaccine adjuvants in autoimmune-prone NZB/W F1 mice: relative efficacy and safety.Insertional hypermutation in mineral oil-induced plasmacytomasPathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.Murine models of systemic lupus erythematosusResveratrol possesses protective effects in a pristane-induced lupus mouse model.Immunopathogenesis of environmentally induced lupus in mice.RORγt modulates macrophage recruitment during a hydrocarbon oil-induced inflammationType I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane)Lupus Nephritis: Animal Modeling of a Complex Disease Syndrome Pathology.Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristaneCluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional studySpecific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies.B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus.Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient miceInterleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice.Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.Maintenance of anti-Sm/RNP autoantibody production by plasma cells residing in ectopic lymphoid tissue and bone marrow memory B cells.Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.Establishing a tree shrew model of systemic lupus erythematosus and cell transplantation treatment.Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection.Colocalization of antigen-specific B and T cells within ectopic lymphoid tissue following immunization with exogenous antigen.Infection and autoimmunity: Lessons of animal models.Adjuvants and autoimmunity.Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice.Immunity and autoimmunity to dsDNA and chromatin--the role of immunogenic DNA-binding proteins and nuclease deficiencies.Mycobacteria, an environmental enhancer of lupus nephritis in a mouse model of systemic lupus erythematosus.Adjuvants- and vaccines-induced autoimmunity: animal models.
P2860
Q24650398-3E0EA850-55AA-410F-9427-36236B6F36BAQ28088753-80047950-1447-4AAC-8E03-74E35B731940Q28378842-0A526695-81A3-48B7-93EF-08D43250607FQ30388433-F5E609E9-4AA7-4A44-938C-1864D656E4F5Q33703190-B481A6C2-71F0-4297-83C0-C4AD69E6815AQ33803417-469C911D-7FE6-4C1B-8603-3A56B4163471Q33806541-38CE5B6F-332F-42E5-B5E7-E940A73BA8B0Q33998320-864769BF-60C9-45A8-BD5B-AC3D9CCE8C8AQ34016334-36694DD9-0FE1-48C7-83D6-0CEA825E75FCQ34056902-1D95FCD8-AFEF-4C6F-9114-E4C5C9AE26E3Q34195705-A75E200C-749A-4435-88C5-3943EEF86624Q34340333-FE772F2A-A3D1-4344-B665-2DC0FCC4D6DFQ34591019-047F24AD-0875-4C1C-8FE4-BB1418D897D8Q34681462-A75AAD68-0C52-4203-8DF8-AAFE18F81986Q35029474-82670C20-1094-413D-9A3E-CAD349DC772FQ35048482-7AD5A088-D020-4621-B64F-97DFD1D971F7Q35088161-F3721E64-A5E0-4636-9D61-F7717E73D0EFQ35110038-C8107B2B-5038-4273-A28B-FA01D543E365Q35249080-E86A1CDD-13B0-49C7-B50A-6DCD57B554D3Q35677926-ADEE8DE6-866D-48F6-97BD-12619D2404CEQ36084984-70615B8F-F53F-4B2C-A51D-5339DBCE0097Q36091161-D95B6193-1E53-4ED7-9E50-4776B41241C4Q36371686-754F7646-30D8-45DD-8DB7-AAF021123CBFQ36404163-65832BFF-1F79-46F7-824C-7ABBE1741B69Q36494607-302558DE-22A9-4014-834F-5DB3B20293A5Q36536967-A2F18D77-B848-428E-B25E-D7A66872B088Q36754463-B30E372B-9DE3-47FB-9B53-39F4930F5DB6Q37006437-1666CE7F-1616-48FB-9397-0DEFEA09313BQ37019634-BA094865-2E23-4F5D-BA55-D0F83DA925E2Q37199240-E013472F-5E8A-46DC-9894-074CEAA7F7F3Q37350900-DEEB4CD9-6A75-44AC-AD87-66ABF3C844F7Q37351980-DD72A037-7255-477A-BEDD-F590FB107F3EQ37361762-5829C1B8-BC9F-4E58-B337-4B9B8894BFE9Q37403161-D3551E9C-605F-403B-A7BB-ED33D7E99EE6Q37531246-E4350787-D592-4857-A331-1BBFC233B108Q37625591-EE296150-7BE2-4091-A568-DB4F9013D32AQ37765141-E63D4CD8-51B1-4421-8B92-143AF33BCAD4Q38046639-9F0FFB9C-C920-43A8-9998-D5C3AB2394E6Q38485977-EA034B04-8ADE-4D2B-9270-9BC884722CD4Q38841755-2DF2B1D7-5D2C-4F2A-921A-CADD8563EECB
P2860
Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Anti-nuclear antibody producti ...... /c mice treated with pristane.
@ast
Anti-nuclear antibody producti ...... /c mice treated with pristane.
@en
type
label
Anti-nuclear antibody producti ...... /c mice treated with pristane.
@ast
Anti-nuclear antibody producti ...... /c mice treated with pristane.
@en
prefLabel
Anti-nuclear antibody producti ...... /c mice treated with pristane.
@ast
Anti-nuclear antibody producti ...... /c mice treated with pristane.
@en
P2093
P2860
P356
P1476
Anti-nuclear antibody producti ...... /c mice treated with pristane.
@en
P2093
P2860
P304
10934-10938
P356
10.1073/PNAS.92.24.10934
P407
P577
1995-11-01T00:00:00Z